membre depuis:
Portefeuille démarré:
Dernière connexion:
10-10-17
12-10-17
05-05-26 10:53
Positions en cours
| Date | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
| 24/02/25 | OSE IMMUNOTHERAPEUTICS | Achat | 500 E | 6.93 | 3.70 | -46.82% | -234 |
|
0 |
| 17/12/24 | COGELEC SA | Achat | 500 E | 15.50 | 29.20 | 88.10% | 441 |
|
0 |
| 06/11/24 | MEDINCELL SA | Achat | 400 E | 15.22 | 25.78 | 69.11% | 276 |
|
0 |
| 28/10/24 | VALBIOTIS | Achat | 400 E | 1.27 | 1.11 | -12.47% | -50 |
|
0 |
| 28/10/24 | VALBIOTIS | Achat | 400 E | 1.34 | 1.11 | -17.05% | -68 |
|
0 |
| 22/10/24 | ADOCIA | Achat | 400 E | 8.51 | 4.11 | -51.90% | -208 |
|
0 |
| 21/10/24 | ADOCIA | Achat | 400 E | 7.65 | 4.11 | -46.48% | -186 |
|
0 |
| 02/10/24 | ADVICENNE | Achat | 500 E | 2.25 | 1.20 | -46.82% | -234 |
|
0 |
| 02/10/24 | ADVICENNE | Achat | 400 E | 2.29 | 1.20 | -47.75% | -191 |
|
0 |
| 01/10/24 | ADVICENNE | Achat | 400 E | 1.62 | 1.20 | -26.10% | -104 |
|
0 |
| 30/09/24 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 8.11 | 3.70 | -54.57% | -218 |
|
0 |
| 23/09/24 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 7.41 | 3.70 | -50.27% | -151 |
|
0 |
| 19/09/24 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 7.76 | 3.70 | -52.52% | -210 |
|
0 |
| 17/09/24 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 7.24 | 3.70 | -49.10% | -196 |
|
0 |
| 22/08/24 | VALBIOTIS | Achat | 400 E | 1.79 | 1.11 | -37.93% | -152 |
|
0 |
| 05/06/24 | VALBIOTIS | Achat | 400 E | 2.31 | 1.11 | -51.92% | -208 |
|
0 |
| 29/05/24 | ADVICENNE | Achat | 400 E | 2.47 | 1.20 | -51.57% | -206 |
|
0 |
| 29/05/24 | ADVICENNE | Achat | 400 E | 2.54 | 1.20 | -52.90% | -212 |
|
24 |
| 10/05/24 | MEDINCELL SA | Achat | 400 E | 14.96 | 25.78 | 72.05% | 288 |
|
0 |
| 10/05/24 | MEDINCELL SA | Achat | 400 E | 15.10 | 25.78 | 70.46% | 282 |
|
0 |
| 08/04/24 | ADOCIA | Achat | 400 E | 10.38 | 4.11 | -60.58% | -242 |
|
0 |
| 25/03/24 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 4.57 | 3.70 | -19.31% | -77 |
|
0 |
| 21/03/24 | REWORLD MEDIA | Achat | 400 E | 3.21 | 1.62 | -49.68% | -199 |
|
0 |
| 18/12/23 | INNATE PHARMA | Achat | 400 E | 2.34 | 1.54 | -34.35% | -137 |
|
0 |
| 08/11/23 | VALBIOTIS | Achat | 400 E | 6.46 | 1.11 | -82.87% | -331 |
|
0 |
| 19/09/23 | ADVICENNE | Achat | 500 E | 2.39 | 1.20 | -49.94% | -250 |
|
0 |
| 18/09/23 | ADVICENNE | Achat | 400 E | 2.42 | 1.20 | -50.56% | -202 |
|
0 |
| 14/06/23 | VALBIOTIS | Achat | 400 E | 4.32 | 1.11 | -74.34% | -297 |
|
0 |
| 13/06/23 | INNATE PHARMA | Achat | 400 E | 3.20 | 1.54 | -52.02% | -208 |
|
0 |
| 23/09/21 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 11.16 | 3.70 | -67.01% | -268 |
|
7 |
| 23/09/21 | INNATE PHARMA | Achat | 400 E | 6.15 | 1.54 | -75.08% | -300 |
|
7 |
| 21/09/21 | INNATE PHARMA | Achat | 400 E | 5.92 | 1.54 | -74.11% | -296 |
|
7 |
| 15/04/21 | VALBIOTIS | Achat | 400 E | 7.92 | 1.11 | -86.05% | -344 |
|
7 |
| 14/04/21 | VALBIOTIS | Achat | 400 E | 8.19 | 1.11 | -86.51% | -346 |
|
5 |
| 31/03/21 | ADVICENNE | Achat | 400 E | 12.00 | 1.20 | -90.11% | -360 |
|
7 |
| 16/03/21 | VALBIOTIS | Achat | 400 E | 7.84 | 1.11 | -85.91% | -344 |
|
7 |
| 10/02/21 | VALBIOTIS | Achat | 300 E | 7.56 | 1.11 | -85.38% | -256 |
|
7 |
| 04/02/21 | VALBIOTIS | Achat | 300 E | 6.98 | 1.11 | -84.16% | -252 |
|
4 |
| 21/01/21 | VALBIOTIS | Achat | 300 E | 6.78 | 1.11 | -83.69% | -251 |
|
8 |
| 27/11/20 | INNATE PHARMA | Achat | 300 E | 4.47 | 1.54 | -65.68% | -197 |
|
8 |
| 12/11/20 | INNATE PHARMA | Achat | 300 E | 3.82 | 1.54 | -59.83% | -179 |
|
7 |
| 11/11/20 | INNATE PHARMA | Achat | 300 E | 3.85 | 1.54 | -60.14% | -180 |
|
4 |
| 10/09/20 | INNATE PHARMA | Achat | 300 E | 3.39 | 1.54 | -54.72% | -164 |
|
7 |
| 09/09/20 | INNATE PHARMA | Achat | 300 E | 3.68 | 1.54 | -58.29% | -175 |
|
5 |
| 25/05/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 5.80 | 3.70 | -36.44% | -109 |
|
8 |
| 30/04/20 | ADVICENNE | Achat | 300 E | 8.82 | 1.20 | -86.51% | -260 |
|
6 |
| 24/04/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 5.02 | 3.70 | -26.55% | -80 |
|
7 |
| 23/04/20 | INNATE PHARMA | Achat | 300 E | 6.33 | 1.54 | -75.80% | -227 |
|
7 |
| 21/04/20 | INNATE PHARMA | Achat | 300 E | 6.39 | 1.54 | -76.02% | -228 |
|
7 |
| 20/04/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 4.38 | 3.70 | -15.80% | -47 |
|
6 |
| Enregistrements 1 à 50 sur 54 | |||||||||
Positions soldées
| Date sortie | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
| 15/11/18 | ACTEOS | Achat | 300 E | 2.15 | 1.46 | -32.26% | -97 | |
15 |
| 24/10/18 | LUMIBIRD | Achat | 600 E | 7.30 | 11.60 | 58.65% | 352 | |
8 |
| 24/10/18 | LUMIBIRD | Achat | 600 E | 15.64 | 11.60 | -26.01% | -156 | |
10 |
| 19/10/18 | LUMIBIRD | Achat | 600 E | 7.48 | 13.28 | 77.26% | 464 | |
8 |
| 19/10/18 | ACTEOS | Achat | 600 E | 5.96 | 1.81 | -69.76% | -419 | |
15 |
| 17/10/18 | ROCTOOL SA | Achat | 600 E | 7.34 | 5.10 | -30.69% | -184 | |
12 |
| 16/10/18 | PHARNEXT | Achat | 300 E | 9.44 | 11.40 | 20.54% | 62 | |
12 |
| 16/10/18 | PHARNEXT | Achat | 300 E | 9.34 | 11.00 | 17.56% | 53 | |
3 |
| 05/10/18 | LUMIBIRD | Achat | 600 E | 6.81 | 13.44 | 97.06% | 582 | |
9 |
| 04/10/18 | ROCTOOL SA | Achat | 600 E | 6.91 | 5.00 | -27.81% | -167 | |
7 |
| 06/09/18 | EUROFINS SCIENTIFIC SE | Achat | 300 E | 462.00 | 460.40 | -0.55% | -2 | |
7 |
| 03/09/18 | VALNEVA SE | Achat | 600 E | 3.63 | 4.00 | 9.98% | 60 | |
12 |
| 23/08/18 | RIBER | Achat | 600 E | 2.67 | 3.48 | 30.11% | 181 | |
6 |
| 23/08/18 | RIBER | Achat | 1 000 E | 3.95 | 3.48 | -12.09% | -121 | |
10 |
| 23/08/18 | VALNEVA SE | Achat | 600 E | 3.44 | 4.00 | 16.06% | 96 | |
8 |
| 15/08/18 | ACTEOS | Achat | 600 E | 5.12 | 3.09 | -39.81% | -239 | |
19 |
| 13/08/18 | LNA SANTE
|
DIV | 0 E | 0.00 | 0.32 | 0.00% | 3 | |
4 |
| 13/08/18 | LNA SANTE
|
DIV | 0 E | 0.00 | 0.32 | 0.00% | 3 | |
5 |
| 13/08/18 | LNA SANTE
|
DIV | 0 E | 0.00 | 0.32 | 0.00% | 3 | |
5 |
| 13/08/18 | LNA SANTE
|
DIV | 0 E | 0.00 | 0.32 | 0.00% | 3 | |
4 |
| 07/08/18 | RIBER
|
DIV | 0 E | 0.00 | 0.05 | 0.00% | 13 | |
5 |
| 07/08/18 | RIBER
|
DIV | 0 E | 0.00 | 0.05 | 0.00% | 11 | |
5 |
| 01/08/18 | VALNEVA SE | Achat | 600 E | 3.20 | 4.15 | 29.46% | 177 | |
8 |
| 12/07/18 | EUROFINS SCIENTIFIC SE
|
DIV | 0 E | 0.00 | 2.04 | 0.00% | 2 | |
5 |
| 12/07/18 | EUROFINS SCIENTIFIC SE
|
DIV | 0 E | 0.00 | 2.04 | 0.00% | 2 | |
3 |
| 03/07/18 | CATANA GROUP | Achat | 600 E | 3.63 | 2.76 | -24.14% | -145 | |
5 |
| 14/06/18 | ACTIA GROUP
|
DIV | 0 E | 0.00 | 0.12 | 0.00% | 9 | |
3 |
| 14/06/18 | ACTIA GROUP
|
DIV | 0 E | 0.00 | 0.12 | 0.00% | 9 | |
3 |
| 14/06/18 | ACTIA GROUP
|
DIV | 0 E | 0.00 | 0.12 | 0.00% | 10 | |
4 |
| 31/05/18 | SOCIETE GENERALE
|
DIV | 0 E | 0.00 | 2.20 | 0.00% | 46 | |
2 |
| 22/05/18 | CREDIT AGRICOLE
|
DIV | 0 E | 0.00 | 0.63 | 0.00% | 42 | |
3 |
| 14/05/18 | INNATE PHARMA | Achat | 600 E | 9.77 | 6.65 | -32.10% | -193 | |
10 |
| 14/05/18 | INNATE PHARMA | Achat | 600 E | 5.00 | 6.64 | 32.57% | 195 | |
14 |
| 26/04/18 | RIBER | Achat | 1 000 E | 3.81 | 3.92 | 2.68% | 27 | |
13 |
| 24/04/18 | EUROFINS SCIENTIFIC SE | Achat | 600 E | 388.20 | 399.80 | 2.79% | 17 | |
5 |
| 18/04/18 | INNATE PHARMA | Achat | 1 000 E | 5.00 | 6.80 | 35.76% | 358 | |
8 |
| 13/04/18 | ROCTOOL SA | Achat | 600 E | 7.02 | 7.15 | 1.65% | 10 | |
6 |
| 09/04/18 | LUMIBIRD | Achat | 600 E | 7.20 | 9.48 | 31.44% | 189 | |
10 |
| 05/04/18 | OSE IMMUNOTHERAPEUTICS | Achat | 600 E | 3.71 | 4.84 | 30.23% | 181 | |
18 |
| 29/03/18 | THERADIAG | Achat | 600 E | 2.30 | 1.75 | -24.09% | -145 | |
9 |
| 07/03/18 | BASTIDE LE CONFORT | Achat | 600 E | 44.70 | 46.50 | 3.82% | 23 | |
5 |
| 07/03/18 | BASTIDE LE CONFORT | Achat | 600 E | 46.40 | 46.50 | 0.02% | 0 | |
14 |
| 27/02/18 | OSE IMMUNOTHERAPEUTICS | Achat | 600 E | 4.14 | 3.95 | -4.78% | -29 | |
10 |
| 08/02/18 | SOCIETE GENERALE | Achat | 600 E | 46.01 | 45.99 | -0.24% | -1 | |
4 |
| 06/02/18 | MAUNA KEA TECHNOLOGIES | Achat | 600 E | 5.19 | 3.02 | -41.97% | -252 | |
6 |
| 06/02/18 | MAUNA KEA TECHNOLOGIES | Achat | 600 E | 5.08 | 3.02 | -40.71% | -244 | |
4 |
| 31/01/18 | BASTIDE LE CONFORT | Achat | 600 E | 44.90 | 52.50 | 16.71% | 100 | |
11 |
| 25/01/18 | ABIONYX PHARMA | Achat | 600 E | 2.07 | 2.70 | 30.20% | 181 | |
9 |
| 25/01/18 | ABIONYX PHARMA | Achat | 600 E | 2.34 | 2.62 | 11.75% | 71 | |
7 |
| 23/01/18 | GENOMIC VISION | Achat | 600 E | 3.46 | 3.19 | -8.00% | -48 | |
7 |
| Enregistrements 1101 à 1150 sur 1162 | |||||||||



